Control of Physical and Biochemical Parameters Influencing Exogeneous Cargo Protein Association to Extracellular Vesicles Using Lipid Anchors Enables High Loading and Effective Intracellular Delivery.

Every cell in our body naturally releases tiny bubble-like packages called extracellular vesicles, or EVs. These EVs are one of the ways cells communicate with each other, delivering molecular cargo from one cell to another. Because of this natural delivery ability, scientists have been excited about the idea of using EVs to ferry medically useful proteins into cells — potentially opening new treatment options for various diseases. There's a catch, though. While EVs are naturally good at carrying certain types of cargo, getting them to efficiently carry protein-based drugs that don't naturally belong there has proven surprisingly difficult. Only small amounts of the desired protein typically end up loaded into each EV, which limits how useful this delivery method can be in practice. One promising workaround that has recently emerged involves attaching cargo to the EV using a "lipid anchor" — essentially a fatty molecular tail that can insert itself into the greasy outer membrane of the EV, hooking the cargo onto its surface. While this anchoring strategy has shown promise for some applications, no one had yet carefully tested whether it works well specifically for delivering proteins into cells, or systematically figured out which factors matter most for making it work efficiently. This study set out to fill that gap. The researchers used precise, quantitative laboratory techniques — including methods capable of studying individual nanoparticles one at a time — to figure out exactly what conditions allow the most cargo protein to be successfully loaded onto EVs, and whether that loaded cargo could still be delivered effectively into cells afterward. They identified several key factors that made a real difference: the temperature at which the loading process took place, how much cargo protein was used, the specific chemical structure of the lipid anchor (including both the fatty portion and the connecting piece linking it to the protein), and even which type of cell the EVs originally came from. By carefully fine-tuning these variables, the researchers were able to load cargo protein onto EVs at levels approaching their maximum capacity, without compromising the EVs' ability to actually deliver that cargo once inside a cell. Interestingly, the specific design of the lipid anchor didn't just affect how well the protein stuck to the EV in the first place — it also influenced how effectively the cargo was ultimately delivered into different types of cancer cells tested in the study. By methodically studying and clearly defining how this lipid-anchoring approach works, the researchers demonstrated that it's a genuinely tunable and controllable strategy — one that can be precisely adjusted to optimize how well protein cargo attaches to EVs and how effectively it gets delivered into target cells. This work strengthens the case for using engineered EVs as a practical, adaptable delivery platform for future protein-based therapies, potentially helping bring this promising technology closer to real-world medical use.